Home・Akcijų sąrašas・Compugen Ltd

Compugen Ltd

Uždarymo kaina

2.38 -3.64

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.35

Max

2.4699999999999998

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-65M -7.7M
Pardavimai	-65M 2.2M
P/E Sektoriaus vid.	6.211 60.549
Pelnas, tenkantis vienai akcijai	-0.08
Pelno marža	-352.436
Darbuotojai	75
EBITDA	-64M -7.7M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+89.07% upside

Dividendai
By Acuity
Kitas uždarbis	2026-08-05

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-47M 223M
Ankstesnė atidarymo kaina	6.02
Ankstesnė uždarymo kaina	2.38

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-10 23:56; UTC

Wynn Resorts shares are trading lower in after-market hours. Broader market volatility and rising treasury yields may be impacting sentiment for casino stocks.

2026-07-10 23:56; UTC

Vanguard Mortgage-Backed Securities ETF remains roughly flat in after-market trading, positioned near the lower end of its one-month trading range.

2026-07-10 23:56; UTC

Social Media

Baidu Inc. shares are lower in after-market trading amid regulatory scrutiny over AI technologies and security concerns regarding U.S.-China relations.

2026-07-10 23:56; UTC

No specific news was identified for Intuit Inc. during after-market hours, with trading activity remaining relatively flat since Friday's close.

2026-07-10 23:56; UTC

ETF Constituents

Health Care Select Sector SPDR Fund trades roughly flat after-market hours, impacted by declines in holdings like Thermo Fisher Scientific and Eli Lilly.

2026-07-10 23:51; UTC

Mixed Asia equity markets as Japan's Nikkei rises on AI rally while China's A50 falls; U.S. futures flat ahead of earnings season amid geopolitical tensions and inflation concerns.

2026-07-10 23:51; UTC

U.S. equity indices remain flat as investors weigh upcoming earnings and inflation reports amid geopolitical tensions and mixed global market performance.

2026-07-10 23:51; UTC

Global equity markets remain flat as investors weigh mixed economic signals and geopolitical tensions ahead of earnings season.

2026-07-10 23:51; UTC

Europe's equity markets remain flat as mixed economic data and geopolitical tensions weigh, while the Bank of England hints at potential interest rate hikes amid rising inflation concerns.

2026-07-10 23:51; UTC

Canada's Housing Starts Data for June 2026 Set to Release with Analysts Forecasting 260K Units Amid Government Initiatives to Tackle Housing Crisis.

2026-07-10 23:51; UTC

NetEase Inc. shares are higher in after-market trading, gaining since Friday's close and remaining near the upper end of their one-month trading range.

2026-07-10 23:51; UTC

ETF Constituents

Social Media

Vanguard Value ETF trades lower in after-market hours as holdings decline. Despite this, value stocks reached a record weekly high.

2026-07-10 23:51; UTC

ETF Constituents

VanEck Gold Miners ETF advances in after-market trading, supported by positive returns from GOLD and AGI, despite flat global equity indices.

2026-07-10 23:51; UTC

Skyworks Solutions Inc shares are higher in after-market trading, reflecting a steady increase since Friday's close without any specific news driving the movement.

2026-07-10 23:46; UTC

Social Media

ETF Constituents

SPDR S&P 500 ETF Trust shows stability in after-market trading, gaining since Friday's close and nearing all-time highs amid bullish market sentiment.

2026-07-10 23:46; UTC

Biomarin Pharmaceutical shares are lower in after-market trading, retracing from earlier highs. No specific news was identified to explain the movement.

2026-07-10 23:46; UTC

Macro News

ETF Constituents

After-market trading for the Communication Services Select Sector SPDR Fund shows strength, supported by gains in Meta Platforms and other key holdings.

2026-07-10 23:46; UTC

ETF Constituents

Global X Copper Miners ETF declines after-market, remaining near the lower end of its one-month trading range amid ongoing geopolitical tensions regarding Iran.

2026-07-10 23:46; UTC

ETF Constituents

Social Media

Invesco QQQ Trust Series I gains in after-market hours, supported by bullish social media sentiment and strong performances from top contributors like Amazon and Applied Materials.

2026-07-10 23:41; UTC

ETF Constituents

Financial Select Sector SPDR Fund declines in after-market trading, impacted by negative returns from Mastercard, American Express, and others despite broader market gains.

2026-07-10 23:41; UTC

US Producer Price Inflation Expected to Rise 0.2% in July Amid Cautious Economic Sentiment and Geopolitical Tensions

2026-07-10 23:41; UTC

U.S. Core Producer Prices Expected to Rise 0.4% in July Amid Ongoing Inflation Concerns and Geopolitical Tensions

2026-07-10 23:41; UTC

Mixed market sentiment prevails as investors await the NY Empire State Manufacturing Index and key inflation reports amid geopolitical tensions.

2026-07-10 23:41; UTC

Macro News

Correlated Moves

Bitcoin is trading higher, supported by market sentiment and Circle Internet Group's approval for a national trust bank for digital asset custody services.

2026-07-10 23:36; UTC

ETF Constituents

The iShares Core MSCI EAFE ETF is trading lower in after-market hours, with declines from top holdings like Novo Nordisk and SAP.

2026-07-10 23:36; UTC

Invesco DB Agriculture Fund trades roughly flat in after-market hours. This stability aligns with mixed signals from recent economic data and geopolitical developments.

2026-07-10 23:31; UTC

Brazil's Retail Sales MoM Release on July 16, 2026: Market Cautious Amid Mixed Reports and Rising Inflation Concerns.

2026-07-10 23:26; UTC

Charter Communications Inc shares are slightly higher in after-market hours, continuing an upward trend since Friday's close amid broader geopolitical concerns.

2026-07-10 23:26; UTC

Cintas Corp shares were roughly flat during after-market hours, reflecting routine trading activity. The asset remains near the upper end of its one-month range.

2026-07-10 23:26; UTC

ETF Constituents

The iShares MSCI Brazil ETF is trading higher in after-market hours, supported by PBR.A, despite a slight decline in PBR. Global indices remain flat.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

89.07% į viršų

12 mėnesių prognozė

Vidutinis 4.67 USD 89.07%

Aukščiausias 5 USD

Žemiausias 4 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

Pirkti

Laikyti

Parduoti

Remiantis 3 analitikų, pateikusių Compugen Ltd akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.